Apr 03, 2017 11:30 am UTC| Business
BEVERLY, Mass., April 03, 2017 -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), is pleased to share further data supporting the p53 mechanism of action of Kevetrin in Ovarian Cancer (OC) at the American...
Apr 03, 2017 11:30 am UTC| Business
VANCOUVER, British Columbia, April 03, 2017 -- Balmoral Resources Ltd. (“Balmoral” or the “Company”) (TSX:BAR) (OTCQX:BALMF) announced that the Company has filed an updated technical report for the Martiniere Property,...
Coupa Software Files Registration Statement for Proposed Follow-on Offering
Apr 03, 2017 11:30 am UTC| Business
SAN MATEO, Calif., April 03, 2017 -- Coupa Software Incorporated (NASDAQ:COUP), a leader in cloud-based spend management, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities...
Apr 03, 2017 11:30 am UTC| Business
BASKING RIDGE, N.J., April 03, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company advancing a select therapeutic development pipeline,announces today that four...
ChinaNet Online Holdings Reports Fiscal Year 2016 Financial Results
Apr 03, 2017 11:30 am UTC| Business
Revenues of $34.8 million in 2016, up 7.7% from prior year's $32.3 millionSearch engine marketing service revenue increased 59.0% to $17.6 million for the yearGross profit of $7.8 million generated in 2016, a 1.9% increase...
Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
Apr 03, 2017 11:30 am UTC| Business
Target Exceeded with More than 160 Patients Enrolled Top-Line Data on Track for 3Q17 CRANBURY, N.J., April 03, 2017 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of therapies...
Apr 03, 2017 11:30 am UTC| Business
- MGL-3196, a liver-directed thyroid hormone receptor (THR) beta selective agonist, has the potential to treat NASH (non-alcoholic steatohepatitis) and familial hypercholesterolemia (FH) - - Madrigal is well positioned...